Nutrição mineral de hortaliças. XLIX. concentração e acúmulo de macronutrientes em alface (Lactuca sativa L.) Cv. Brasil 48 e Clause's Aurélia

Com os objetivos de: - obter e analisar o crescimento dos cultivares; - determinar a concentração e extração de macronutrientes nas plantas em função da idade. Foi realizado um ensaio de campo no qual os dois cultivares foram plantados colhendo-se plantas aos 20, 30, 40, 50, 60 e 70 dias de idade após o transplante. Determinou-se a produção de matéria seca e as concentrações de macronutrientes. Observou-se que o crescimento e a extração de nutrientes foi lenta no ensaio sofrendo aceleração a partir dos 30 dias, mantendo-se intensos e não alcançando o ponto de máxima acumulação até a colheita. O crescimento expresso de produção de matéria seca, foi semelhante para os dois cultivares, 12,7 g/planta para o cultivar Brasil 48 e 12,5 g/planta para o cultuvar Clause's Aurélia. Porcentagens acima de 59 da matéria seca e entre 43% a 69% dos nutrientes foram acumuladas pelos dois cultivares durante os 20 dias que antecederam a colheita. Uma planta do cultivar Brasil 48 acumulou por ocasião da colheita 469 mg N, 100 mg P, 1017 mg K, 161 mg Ca, 47 mg Mg e 21 mg S. Quantidades semlehantes foram acumuladas por uma planta do cultivar Clause's Aurélia - 410 mg N, 100 mg P, 759 mg K, 200 mg Ca, 52 mg Mg e 21 mg S.

Nutrição mineral de hortaliças. XL. concentração e acúmulo de micronutrientes em alface (Lactuca sativa L.) Cv. Brasil 48 e Clause's Aurélia

Com os objetivos de: - Determinar a concentração e acumulação de B, Cu, Fe, Mn e Zn nos cultivares Brasil 48 e Clause's Aurélia em função da idade. Foi conduzido um ensaio de campo em Piracicaba, São Paulo sobre o solo Terra Roxa Estruturada, série "Luiz de Queiroz" que vem sendo cultivado com hortaliças há mais de 50 anos. Mudas com 20 dias foram transplantadas para um espaçamento de 0,30 x 0,25 m. A adubação constou em aplicação de 200 g por metro quadrado da fórmula 4-14-10. Aos 20 e 40 dias após o transplante foi aplicado 5 g de sulfato de amônio por planta. A cultura foi irrigada sempre que necessário. As amostragens foram feitas por ocasião do transplante e depois a intervalos de dez dias aproximadamente. As plantas foram cortadas rente ao solo, lavadas, secas e analisadas para B, Cu, Fe, Mn e Zn de acordo com as instruções contidas em SARRUGE & HAAG (1974). Houve diferenças na concentração de nutrientes, mostrando-se o cultivar Brasil 48 mais exigente. Os cultivares Brasil 48 e Clause's Aurélia acumularam ao final do ciclo respectivamente, 896 g e 958 µg de B, 196µg e 168 µg de Cu, 6800 µg de Fe, 3534 µg e 1025 µg de Mn, 4462 µg e 2425 µg de Zn.

Transmission blocking immunity as observed in a feeder system and serological reactivity to Pfs 48/45 and Pfs230 in field sera

Monoclonal antibodies (mAbs) and human sera from gametocyte carriers were applied in the bio-assay to test for their transmission-blocking capacity. Competition ELISA's have been developed for the detection of natural transmission blocking antibodies. Approximately 55 of the sera blocking in the bio-assay gave positive results in these competition ELISA's.

The Growth of Brown Adipose Tissue in Cold-acclimatized Rats after Depletion of Mast Cell Histamine by Compound 48/80

Cold acclimatization (4-5°C) is accompanied by 2-3 fold increase of brown adipose tissue (BAT). This rapid growth of interscapular BAT was studied after histamine depletion. In control rats maintained at room temperature (28 ± 2°C) the BAT histamine content was 23.4 ± 5.9 (mean ± SD) µg/g of tissue and cold acclimatization (5±1°C) produced a significant increase of BAT weight, but reduced the histamine content to 8.4 ± 1.9 µg/g. The total weight of BAT after 20 days of acclimatization was unaffected by depletion of histamine due to compound 48/80. The low level of histamine in BAT of cold acclimatized rats could be due to a fast rate of amine utilization; alternatively an altered synthesis or storage process may occur during acclimatization.

Charges for Residential Accommodation Guide 01/2005 (PDF 48 KB)

Charges for Residential Accommodation

Prevalence and Clinical Characteristics of HIV Type 1-Infected Patients Receiving Dialysis in Spain: Results of a Spanish Survey in 2006: GESIDA 48/05 Study

End-stage renal diseases (ESRD) are becoming more frequent in HIV-infected patients. In Europe there is little information about HIV-infected patients on dialysis. A cross-sectional multicenter survey in 328 Spanish dialysis units was conducted in 2006. Information from 14,876 patients in dialysis was obtained (81.6% of the Spanish dialysis population). Eighty-one were HIV infected (0.54%; 95% CI, 0.43-0.67), 60 were on hemodialysis, and 21 were on peritoneal dialysis. The mean (range) age was 45 (28-73) years. Seventy-two percent were men and 33% were former drug users. The mean (range) time of HIV infection was 11 (1-27) years and time on dialysis was 4.6 (0.4-25) years. ESRD was due to glomerulonephritis (36%) and diabetes (15%). HIV-associated nephropathy was not reported. Eighty-five percent were on HAART, 76.5% had a CD4 T cell count above 200 cells, and 73% had undetectable viral load. Thirty-nine percent of patients met criteria for inclusion on the renal transplant (RT) waiting list but only 12% were included. Sixty-one percent had HCV coinfection. HCV-coinfected patients had a longer history of HIV, more previous AIDS events, parenteral transmission as the most common risk factor for acquiring HIV infection, and less access to the RT waiting list (p < 0.05). The prevalence of HIV infection in Spanish dialysis units in 2006 was 0.54% HCV coinfection was very frequent (61%) and the percentage of patients included on the Spanish RT waiting list was low (12%).

Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction.

Levels of circulating cardiac troponin I (cTnI) or T are correlated to extent of myocardial destruction after an acute myocardial infarction. Few studies analyzing this relation have employed a second-generation cTnI assay or cardiac magnetic resonance (CMR) as the imaging end point. In this post hoc study of the Efficacy of FX06 in the Prevention of Mycoardial Reperfusion Injury (F.I.R.E.) trial, we aimed at determining the correlation between single-point cTnI measurements and CMR-estimated infarct size at 5 to 7 days and 4 months after a first-time ST-elevation myocardial infarction (STEMI) and investigating whether cTnI might provide independent prognostic information regarding infarct size at 4 months even taking into account early infarct size. Two hundred twenty-seven patients with a first-time STEMI were included in F.I.R.E. All patients received primary percutaneous coronary intervention within 6 hours from onset of symptoms. cTnI was measured at 24 and 48 hours after admission. CMR was conducted within 1 week of the index event (5 to 7 days) and at 4 months. Pearson correlations (r) for infarct size and cTnI at 24 hours were r = 0.66 (5 days) and r = 0.63 (4 months) and those for cTnI at 48 hours were r = 0.67 (5 days) and r = 0.65 (4 months). In a multiple regression analysis for predicting infarct size at 4 months (n = 141), cTnI and infarct location retained an independent prognostic role even taking into account early infarct size. In conclusion, a single-point cTnI measurement taken early after a first-time STEMI is a useful marker for infarct size and might also supplement early CMR evaluation in prediction of infarct size at 4 months.